General Archive
-
News releases
MRC Technology calls for diagnostic collaboration
MRC Technology is inviting potential partners with early stage RNA, DNA and/or protein-based diagnostics to submit details and explore collaborative…
-
News releases
MRC Technology welcomes launch of Knowledge Quarter
MRC Technology is a member of the newly launched Knowledge Quarter, set up to create a vibrant knowledge hub by…
-
News releases
MRC Technology and Shandong International Biotechnology Park (China) to cooperate in new drug for Alzheimer’s
MRC Technology and Shandong International Biotechnology Park (BIOasis) have signed a partnership agreement for the development of a new Alzheimer’s…
-
News releases
MRC Technology and Yabao Pharmaceuticals Announce Exclusive Partnership in China to Develop Novel Therapeutics for Parkinson’s Disease
New partnership with Yabao Pharmaceutical Co, Inc. to discover, develop and commercialise innovative compounds targeting a specific kinase involved in…
-
News releases
Charities pledge to jump start drug development for brain diseases
The Neurodegeneration Medicines Acceleration Programme (Neuro-MAP), led by medical research charity MRC Technology, will see charities and funding bodies identify…
-
News releases
Catherine Kettleborough elected to SLAS Europe Council
Congratulations to Catherine Kettleborough, MRC Technology’s Associate Director of Drug Discovery Biology, who has been elected to the SLAS Europe…
-
News releases
MRC Technology and Proximagen Collaborate to Develop Novel Therapeutics for Inflammatory and Autoimmune Disease
Project will investigate a small molecule solution for Macrophage migration inhibitory factor
-
News releases
Dr. John Stageman Appointed Chair of the Board for MRC Technology
London, UK, 29 September 2014: MRC Technology (MRCT), a UK medical research charity, today announced the appointment of Dr. John…
-
News releases
Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology
MRC Technology is pleased to highlight that today Merck, known as MSD outside the United States and Canada, announced FDA…
-
News releases
MRC Technology Announces Humanization of Anti-Tau Monoclonal Antibody for Alzheimer’s Disease Therapy
Antibody inhibits Tau aggregation involved in the pathology of Alzheimer’s and other neurodegenerative diseases
-
News releases
MRC Technology and AstraZeneca renew collaboration to identify novel targets for discovery research
The collaboration focuses on the identification and selection of novel drug targets with the potential to become potent and selective…
-
News releases
Dementia Consortium wins One Nucleus BioNewsRound Award at ON Helix 2014
The award was given for the announcement of the formation of a £3m Dementia Consortium in collaboration with Alzheimer’s Research…